文献速递临床试验与 GCP真实世界研究与卫生经济

护士主导的痛风管理对比常规护理:随机对照试验的疗效与成本效果

Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.
PubMed 文献 · Lancet · 2018-01-01

这项英国随机对照试验纳入517例过去12个月内有痛风发作的成人,比较护士主导的教育与达标降尿酸治疗和全科医生常规护理。

要点

  • 护士主导的痛风管理显著提高血尿酸达标率(95% vs 30%)。
  • 2年时所有次要结局均 favour 护士主导组。
  • 每获得一个QALY的成本为5066英镑,具成本效果。

核心结论

  • 护士主导的痛风护理与常规护理相比有效且具成本效果。
  • 教育和患者参与管理及达标降尿酸策略对改善以患者为中心的结局重要。

研究设计与样本

  • 随机对照试验,1:1分配至护士主导护理或全科医生常规护理。
  • 纳入517例过去12个月内有痛风发作的成人,护士组255例,常规组262例。
  • 研究护士接受痛风最佳实践管理培训,包括提供个体化信息和参与共享决策。
  • 主要结局为2年时血尿酸低于360 μmol/L(6 mg/dL)的参与者百分比。
  • 采用意向性治疗分析和多重插补计算风险比(RR)及95%CI。

主要发现

  • 护士主导护理与降尿酸治疗的高接受度和依从性相关。
  • 2年时所有次要结局均 favour 护士主导组。
  • 护士主导干预每获得一个QALY的成本为5066英镑(2年时)。

关键数值与推荐

  • 主要结局达标阈值:血尿酸低于360 μmol/L(6 mg/dL)。
  • 每QALY成本为5066英镑。

临床怎么用

  • 可考虑由受训护士主导痛风管理,提供个体化教育并engage患者参与决策。
  • 实施达标降尿酸治疗策略,滴定至血尿酸低于360 μmol/L。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the UK, gout management is suboptimum, with only 40% of patients receiving urate-lowering therapy, usually without titration to achieve a target serum urate concentration. Nurses successfully manage many diseases in primary care. We compared nurse-led gout care to usual care led by general practitioners (GPs) for people in the community. METHODS: Research nurses were trained in best practice management of gout, including providing individualised information and engaging patients in shared decision making. Adults who had experienced a gout flare in the previous 12 months were randomly assigned 1:1 to receive nurse-led care or continue with GP-led usual care. We assessed patients at baseline and after 1 and 2 years. The primary outcome was the percentage of participants who achieved serum urate concentrations less than 360 μmol/L (6 mg/dL) at 2 years. Secondary outcomes were flare frequency in year 2, presence of tophi, quality of life, and cost per quality-adjusted life-year (QALY) gained. Risk ratios (RRs) and 95% CIs were calculated based on intention to treat with multiple imputation. This study is registered with www.ClinicalTrials.gov, number NCT01477346. FINDINGS: 517 patients were enrolled, of whom 255 were assigned nurse-led care and 262 usual care. Nurse-led care was associated with high uptake of and adherence to urate-lowering therapy. More patients receiving nurse-led care had serum urate concentrations less than 360 μmol/L at 2 years than those receiving usual care (95% vs 30%, RR 3·18, 95% CI 2·42-4·18, p<0·0001). At 2 years all secondary outcomes favoured the nurse-led group. The cost per QALY gained for the nurse-led intervention was £5066 at 2 years. INTERPRETATION: Nurse-led gout care is efficacious and cost-effective compared with usual care. Our findings illustrate the benefits of educating and engaging patients in gout management and reaffirm the importance of a treat-to-target urate-lowering treatment strategy to improve patient-centred outcomes. FUNDING: Arthritis Research UK.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Doherty M, Jenkins W, Richardson H, et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet. 2018. PMID: 30343856. doi:10.1016/S0140-6736(18)32158-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。